Personnamn
Titel och upphov Budget-Impact Analysis of Health Care Interventions : a Practical Guide.
Utgivning, distribution etc. Springer International Publishing, Cham : 2017.
DDC klassifikationskod (Dewey Decimal Classification)
Fysisk beskrivning 1 online resource (234 pages)
Anmärkning: Allmän 6.2.1 Acute Conditions or Chronic Conditions Where Changes Occur Almost Immediately.
Anmärkning: Innehåll Author Contributions; Foreword; Preface; Abbreviations; Contents; Chapter 1: Introduction to Budget-Impact Analysis; 1.1 What Is Budget-Impact Analysis?; 1.2 Budget-Impact Analyses Compared with Cost-ƯEffectiveness Analyses; 1.3 Uses of Budget-Impact Analyses; 1.4 Guidelines for Budget-Impact Analyses; 1.5 Overview of Chapters in This Book; Exercises; References; Chapter 2: Determining the Analytic Framework; 2.1 Eligible Population in Jurisdiction; 2.1.1 Impact of Positioning of the New Drug Within the Current Treatment Pathway on Eligible Population Size. 2.1.2 Impact of Regulatory Approval on Eligible Population Size2.1.3 Impact of Reimbursement Decisions on Eligible Population Size; 2.1.4 Impact of New Drug Attributes on Initial Population Size; 2.1.5 Impact of New Drug Attributes on Population Size Over Model Time Horizon; 2.2 Budget Holder Time Horizon; 2.3 Potential Use of the New Drug Within the Treatment Mix; 2.4 Budget Holder Cost Perspective; 2.4.1 Service Delivery Cost Versus Reimbursement Rate; 2.4.2 Fixed Versus Variable Costs; 2.4.3 Cost Categories of Interest; 2.5 Compilation of Analytic Framework; Exercises; References. Chapter 3: Estimating the Diagnosed, Treated, and Eligible Population3.1 Incident and Prevalent Populations; 3.2 Estimating the Eligible Population Size; 3.3 Data for Identifying the Eligible Population; 3.4 Estimating Population Size by Subgroup; 3.5 Changing Size of the Eligible Population Over the Analysis Time Horizon; 3.5.1 Changing Population Size Regardless of Introduction of the New Drug; 3.5.2 Changing Population Size and Condition Severity Mix due to the Introduction of the New Drug; 3.6 Including Catch-Up Effects for the Prevalent Population. 3.7 Which Eligible Population Should We Include in the Budget-Impact Analysis?Exercises; References; Chapter 4: Estimating the Treatment Mix; 4.1 Treatment Shares Without the New Drug in the Treatment Mix; 4.2 Treatment Shares with the New Drug in the Treatment Mix; 4.3 Which Treatment Shares Should We Include in the Budget-Impact Analysis?; Exercises; Reference; Chapter 5: Estimating Treatment-Related Costs; 5.1 Costs for Drug Acquisition; 5.1.1 Co-payments and Coinsurance; 5.1.2 Dispensing Fees; 5.1.3 Dose Levels; 5.1.4 Duration of Treatment; 5.2 Costs for Administering the Drug. 5.3 Costs for Diagnostic Tests to Determine Eligibility for the Drug5.4 Costs for Monitoring the Drug for Safety and Efficacy; 5.5 Costs for Treating Side Effects Associated with the Drug; 5.6 Accounting for Differing Treatment Costs in the First and Subsequent Treatment Years; 5.7 Accounting for Other Treatment Costs; 5.8 Estimating Resource Use Changes with the New Drug; Exercises; References; Chapter 6: Estimating Condition-Related Costs; 6.1 Why the New Drug Might Change Condition-Related Costs; 6.2 Estimating Changes in Condition-Related Costs for Incident Populations.
Anmärkning: Innehållsbeskrivning, sammanfattning The first of its kind for budget-impact analysis, this comprehensive guide provides clear and concise instructions for evaluating the impact that new pharmaceuticals will have on the budget for a specific jurisdiction. The book demonstrates how to create a budget-impact analysis using a simple six-step process that is consistent with current guidelines for these analyses. Examples and exercises for each chapter afford an opportunity to practice the six-step process in practical applications. The book progresses from a framework for budget impact analyses to an in-depth review of components and how to develop and present these in software applications and reports. Critical considerations such as uncertainty analysis and validation, and considerations for alternate interventions, such as vaccines and diagnostics, are also covered. This book is a "must have" for the builder and budget holder, with builders benefiting from instructions to identify and estimate all necessary variables and budget holders receiving a guide to what should be included in the analyses they assess.
Term
Genre/Form
Personnamn
Annat medium Print version: Mauskopf, Josephine. Budget-Impact Analysis of Health Care Interventions : A Practical Guide. Cham : Springer International Publishing, ©2017 ISBN 9783319504803
Elektronisk adress och åtkomst (URI) http://link.springer.com/10.1007/978-3-319-50482-7
ISBN
*00000000cam a2200000Mi 4500
*00178962
*00520181120084252.4
*006m o d
*007cr cnu---unuuu
*008170812s2017 xx o 000 0 eng d
*019 $a1000116759$a1004938895$a1004993779$a1005105474$a1011943323$a1013797799$a1048171482
*020 $a9783319504827$q(electronic bk.)
*020 $a3319504827$q(electronic bk.)
*020 $z9783319504803
*020 $z3319504800
*0247 $a10.1007/978-3-319-50482-7$2doi
*029 $aAU@$b000060718392
*035 $a(OCoLC)1000451702$z(OCoLC)1000116759$z(OCoLC)1004938895$z(OCoLC)1004993779$z(OCoLC)1005105474$z(OCoLC)1011943323$z(OCoLC)1013797799$z(OCoLC)1048171482
*035 $a(OCoLC)on1000451702
*040 $aEBLCP$beng$epn$cEBLCP$dN$dYDX$dGW5XE$dOCLCF$dUAB$dAZU$dOCLCQ$dUPM$dMERER$dOCLCQ$dESU$dIOG$dOCL$dCOO$dOCLCO$dOCL$dU3W$dCAUOI$dOCLCQ$dKSU$dVT2
*049 $aMAIN
*050 4$aR1
*072 7$aPOL$x027000$2bisacsh
*072 7$aPOL$x019000$2bisacsh
*072 7$aMMG$2bicssc
*08204$a362.1
*1001 $aMauskopf, Josephine.
*24510$aBudget-Impact Analysis of Health Care Interventions :$ba Practical Guide.
*260 $aCham :$bSpringer International Publishing,$c2017.
*300 $a1 online resource (234 pages)
*336 $atext$btxt$2rdacontent
*337 $acomputer$bc$2rdamedia
*338 $aonline resource$bcr$2rdacarrier
*347 $atext file$bPDF$2rda
*500 $a6.2.1 Acute Conditions or Chronic Conditions Where Changes Occur Almost Immediately.
*5050 $aAuthor Contributions; Foreword; Preface; Abbreviations; Contents; Chapter 1: Introduction to Budget-Impact Analysis; 1.1 What Is Budget-Impact Analysis?; 1.2 Budget-Impact Analyses Compared with Cost-ƯEffectiveness Analyses; 1.3 Uses of Budget-Impact Analyses; 1.4 Guidelines for Budget-Impact Analyses; 1.5 Overview of Chapters in This Book; Exercises; References; Chapter 2: Determining the Analytic Framework; 2.1 Eligible Population in Jurisdiction; 2.1.1 Impact of Positioning of the New Drug Within the Current Treatment Pathway on Eligible Population Size.
*5058 $a2.1.2 Impact of Regulatory Approval on Eligible Population Size2.1.3 Impact of Reimbursement Decisions on Eligible Population Size; 2.1.4 Impact of New Drug Attributes on Initial Population Size; 2.1.5 Impact of New Drug Attributes on Population Size Over Model Time Horizon; 2.2 Budget Holder Time Horizon; 2.3 Potential Use of the New Drug Within the Treatment Mix; 2.4 Budget Holder Cost Perspective; 2.4.1 Service Delivery Cost Versus Reimbursement Rate; 2.4.2 Fixed Versus Variable Costs; 2.4.3 Cost Categories of Interest; 2.5 Compilation of Analytic Framework; Exercises; References.
*5058 $aChapter 3: Estimating the Diagnosed, Treated, and Eligible Population3.1 Incident and Prevalent Populations; 3.2 Estimating the Eligible Population Size; 3.3 Data for Identifying the Eligible Population; 3.4 Estimating Population Size by Subgroup; 3.5 Changing Size of the Eligible Population Over the Analysis Time Horizon; 3.5.1 Changing Population Size Regardless of Introduction of the New Drug; 3.5.2 Changing Population Size and Condition Severity Mix due to the Introduction of the New Drug; 3.6 Including Catch-Up Effects for the Prevalent Population.
*5058 $a3.7 Which Eligible Population Should We Include in the Budget-Impact Analysis?Exercises; References; Chapter 4: Estimating the Treatment Mix; 4.1 Treatment Shares Without the New Drug in the Treatment Mix; 4.2 Treatment Shares with the New Drug in the Treatment Mix; 4.3 Which Treatment Shares Should We Include in the Budget-Impact Analysis?; Exercises; Reference; Chapter 5: Estimating Treatment-Related Costs; 5.1 Costs for Drug Acquisition; 5.1.1 Co-payments and Coinsurance; 5.1.2 Dispensing Fees; 5.1.3 Dose Levels; 5.1.4 Duration of Treatment; 5.2 Costs for Administering the Drug.
*5058 $a5.3 Costs for Diagnostic Tests to Determine Eligibility for the Drug5.4 Costs for Monitoring the Drug for Safety and Efficacy; 5.5 Costs for Treating Side Effects Associated with the Drug; 5.6 Accounting for Differing Treatment Costs in the First and Subsequent Treatment Years; 5.7 Accounting for Other Treatment Costs; 5.8 Estimating Resource Use Changes with the New Drug; Exercises; References; Chapter 6: Estimating Condition-Related Costs; 6.1 Why the New Drug Might Change Condition-Related Costs; 6.2 Estimating Changes in Condition-Related Costs for Incident Populations.
*520 $aThe first of its kind for budget-impact analysis, this comprehensive guide provides clear and concise instructions for evaluating the impact that new pharmaceuticals will have on the budget for a specific jurisdiction. The book demonstrates how to create a budget-impact analysis using a simple six-step process that is consistent with current guidelines for these analyses. Examples and exercises for each chapter afford an opportunity to practice the six-step process in practical applications. The book progresses from a framework for budget impact analyses to an in-depth review of components and how to develop and present these in software applications and reports. Critical considerations such as uncertainty analysis and validation, and considerations for alternate interventions, such as vaccines and diagnostics, are also covered. This book is a "must have" for the builder and budget holder, with builders benefiting from instructions to identify and estimate all necessary variables and budget holders receiving a guide to what should be included in the analyses they assess.
*5880 $aPrint version record.
*590 $aSpringerLink$bSpringer Medicine eBooks 2017 English+International
*650 0$aMedical economics .
*650 7$aPOLITICAL SCIENCE$xPublic Policy$xSocial Security.$2bisacsh
*650 7$aPOLITICAL SCIENCE$xPublic Policy$xSocial Services & Welfare.$2bisacsh
*650 7$aMedical economics .$2fast$0(OCoLC)fst01014004
*655 4$aElectronic books.
*7001 $aEarnshaw, Stephanie R.
*7001 $aBrogan, Anita.
*7001 $aWolowacz, Sorrel.
*7001 $aBrodtkorb, Thor-Henrik.
*77608$iPrint version:$aMauskopf, Josephine.$tBudget-Impact Analysis of Health Care Interventions : A Practical Guide.$dCham : Springer International Publishing, ©2017$z9783319504803
*85640$uhttp://link.springer.com/10.1007/978-3-319-50482-7
*938 $aEBL - Ebook Library$bEBLB$nEBL4939362
*938 $aEBSCOhost$bEBSC$n1570668
*938 $aYBP Library Services$bYANK$n14742825
*994 $a92$bSESKS
^
Det finns inga omdömen till denna titeln.
Klicka här
för att vara den första som skriver ett omdöme.